logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

TRULY INT'L (00732) spent HKD 222,000 on April 27 to repurchase 222,000 shares.

date
17:16 27/04/2026
avatar
GMT Eight
Sunlit International (00732) announced on April 27, 2026 that it will spend 222,000 Hong Kong dollars to repurchase 222,000 shares.
TRULY INT'L (00732) announced that on April 27, 2026, it will buy back 222,000 shares for HKD 222,000.
Related Articles
HK Stock
Zhou Hei Ya (01458) spent HKD 990,600 to repurchase 686,000 shares on April 27th.
HK Stock
In the first quarter, the net profit attributable to the parent company of Cig Shanghai (06166) was 118 million yuan, an increase of 276.44% year-on-year.
HK Stock
Guangzhou Baiyunshan Pharmaceutical Holdings (00874) reported a net profit attributable to shareholders of 1.784 billion yuan in the first quarter, a decrease of 2.06% year-on-year.
Zhou Hei Ya (01458) spent HKD 990,600 to repurchase 686,000 shares on April 27th.
HK Stock
In the first quarter, the net profit attributable to the parent company of Cig Shanghai (06166) was 118 million yuan, an increase of 276.44% year-on-year.
HK Stock
Guangzhou Baiyunshan Pharmaceutical Holdings (00874) reported a net profit attributable to shareholders of 1.784 billion yuan in the first quarter, a decrease of 2.06% year-on-year.
HK Stock
RECOMMEND
iQIYI’s AI Drama Faces Backlash Over Industry Dynamics
iQIYI’s AI Drama Faces Backlash Over Industry Dynamics
icon
26/04/2026
DeepSeek valuation jumps as Tencent and Alibaba reportedly in talks
DeepSeek valuation jumps as Tencent and Alibaba reportedly in talks
icon
26/04/2026
Intel first proposes intelligent PC concept as digital employee era sees “Lobster” and “Hermes” surge
Intel first proposes intelligent PC concept as digital employee era sees “Lobster” and “Hermes” surge
icon
26/04/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.